Andere Sprachen Krystal Biotech, Inc.

Aktien

A2JH2F

US5011471027

KRYS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 23.04.2024			% 5 Tage	% 1. Jan.
162 ^USD	+3.05%		-4.73%	+30.61%

22.04.	Krystal Biotech, Inc. gibt die Verabreichung des ersten Patienten in der klinischen Phase-1-Studie mit inhaliertem KB707 zur Behandlung von lokal fortgeschrittenen oder metastasierten soliden Lungentumoren bekannt	CI
16.04.	KRYSTAL BIOTECH, INC. : erhält Kaufen-Rating von Stifel Nicolaus	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22.04.
Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22.04.
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05.04.
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04.04.
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12.03.
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12.03.
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29.02.
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	28.02.
Sector Update: Health Care Stocks Ease Late Afternoon	26.02.
Sector Update: Health Care Stocks Weaker Monday Afternoon	26.02.
Top Midday Gainers	26.02.
Krystal Biotech Shares Jump After Surprise Q4 Profit	26.02.
Krystal Biotech Swings to Q4 Profit as Company Generates Revenue; Shares Climb Pre-Bell	26.02.
Krystal Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26.02.
Earnings Flash (KRYS) KRYSTAL BIOTECH Posts Q4 EPS $0.30, vs. Street Est of $-0.25	26.02.
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	26.02.
Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.02.
North American Morning Briefing : Traders Await Inflation Data This Week	26.02.
MORNING BID AMERICAS-Booming stocks step back as PCE hoves into view	26.02.
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Krystal Biotech, Inc.

Aktien

A2JH2F

US5011471027

KRYS

Andere Sprachen

Filter